Join our webinar tomorrow at 4:00 PM to see how Ashvattha Therapeutics has discovered a way to deliver therapeutics to activated cells without impacting the healthy ones by using systemic treatments for inflammatory diseases. https://hubs.la/Q02sQTyc0
FORCE Family Office’s Post
More Relevant Posts
-
Join our webinar tomorrow at 4:00 PM to see how Ashvattha Therapeutics has discovered a way to deliver therapeutics to activated cells without impacting the healthy ones by using systemic treatments for inflammatory diseases. https://hubs.la/Q02sQSW40
-
-
Join our webinar tomorrow at 4:00 PM to see how Ashvattha Therapeutics has discovered a way to deliver therapeutics to activated cells without impacting the healthy ones by using systemic treatments for inflammatory diseases. https://hubs.la/Q02sQXKm0
-
-
Join our webinar tomorrow at 4:00 PM to see how Ashvattha Therapeutics has discovered a way to deliver therapeutics to activated cells without impacting the healthy ones by using systemic treatments for inflammatory diseases. https://hubs.la/Q02sQN810
-
-
Join our webinar on April 23rd at 4:00 PM to see how Ashvattha Therapeutics has discovered a way to deliver therapeutics to activated cells without impacting the healthy ones by using systemic treatments for inflammatory diseases. https://hubs.la/Q02sQXHz0
-
-
Join our webinar on April 23rd at 4:00 PM to see how Ashvattha Therapeutics has discovered a way to deliver therapeutics to activated cells without impacting the healthy ones by using systemic treatments for inflammatory diseases. https://hubs.la/Q02sQSpr0
-
-
New data support CAR-T therapy in neuroinflammatory diseases Kyverna Therapeutics has revealed continued positive results for its CAR-T therapy KYV-101 in B cell-driven autoimmune diseases. https://lnkd.in/eBsxGUQN #CellTherapy #DrugDiscovery #NeuroinflammatoryDiseases
-
-
Discovery Life Sciences has a robust #biorepository of #biospecimens available from #autoimmunedisease patients available for immediate shipment to your facility. PBMCs, plasma, serum and FFPE are all available. Send me a DM if you need an inventory report! #PBMCs #FFPE #tissues #rheumatoidarthritis #SLE #lupus #psoriasis #autoimmune #researchanddevelopment #clinicalsamples
Access to a reliable source of diverse patient samples is crucial for studying autoimmune diseases, allowing for faster identification of unique disease patterns and the development of effective therapeutics and diagnostics. Discovery specializes in prospective biospecimen collections and partners with nearly 200 clinical sites globally to provide a diverse range of autoimmune disease patient samples, including SLE, Crohn’s, rheumatoid arthritis, ulcerative colitis, sickle cell anemia, and more. Let us help move your autoimmune disease research forward. Discuss your project with us today: https://lnkd.in/gvV4TREc #autoimmune #biospecimens
-
-
June is #AlzheimersandBrainAwarenessMonth, an important time to raise awareness of the significance of #brainhealth. At Delix Therapeutics, we're developing first-in-class #neuroplastogens that promote the brain's innate ability to repair itself, and in doing so, pioneering a new era in #CNS disease treatment. Learn more about our science here: https://lnkd.in/eCRnJMv5.
-
-
🚀 Continuing Your Pharma Education: Intestinal Diseases – From Inflammatory Conditions to Intestinal Cancer 🩺 In our latest article, we explore intestinal diseases like IBS, IBD, and intestinal cancer, discussing causes, symptoms, and modern treatment approaches. Learn about the latest pharmaceutical strategies for managing these complex conditions. #IntestinalDiseases #IBD #CeliacDisease #PharmaEducation #IntestinalCancer #GutHealth #NewToPharma #PharmaceuticalIndustry #Gastroenterology #MedicalRepresentative #PharmaColleagues #Health #MedicalStudent #HealthTips Read the full article now and stay tuned for more! 👇 https://lnkd.in/dD4f2cEw
-
Join us tomorrow at 11:00 am EST! In this presentation, the speaker will review the existing literature related to the potential mechanisms for increased drug hepatotoxicity in patients with chronic liver diseases such as MASLD and cirrhosis. Learn more: https://lnkd.in/eaecXuEP
-
